There is a newer version of this record available.

Working paper Open Access

Ivermectin for Covid-19

Sparavigna, Amelia Carolina

Discussion of scholar papers published until June 29, 2020,  on Ivermectin, and of news that we can find about its use for Covid-19.  A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv,  which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19.  From news, we consider in particular the case of Iquitos,  capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably. The formulation of ivermectin used in Peru is also discussed, in particular that of the oral solution disclosed by the Peruvian Government.

Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.
Files (248.8 kB)
Name Size
Ivermectin-8.pdf
md5:878440e8be7616aee58e19cc198bb4f8
248.8 kB Download
5,551
2,190
views
downloads
All versions This version
Views 5,551306
Downloads 2,190135
Data volume 718.8 MB33.6 MB
Unique views 4,357249
Unique downloads 1,786119

Share

Cite as